Author(s): Agius RM, Davison AG, Hawkins ER, Newman Taylor AJ
Abstract Share this page
Abstract Occupational asthma after exposure to salbutamol in the pharmaceutical industry has not been previously reported. The occurrence of occupational asthma is described in two pharmaceutical process workers who were likely to have inhaled doses appreciably in excess of the therapeutic dose range. The findings do not lead to an unequivocal conclusion on the mechanism of the asthma but it was probably a pharmacological consequence of high exposure.
This article was published in Occup Environ Med
and referenced in Pharmaceutical Regulatory Affairs: Open Access